Status | Study |
Not yet recruiting |
Study Name: Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I or Isolated Lung Parenchymal Recurrent Non-small Cell Lung Cancer: I-SABR Condition: Malignant Neoplasms of Respiratory and Intrathoracic Organs Non-small Cell Lung Cancer Date: 2017-04-07 Interventions: Radiation: Stereotactic Ablative Radiotherapy |
Recruiting |
Study Name: PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers Condition: Neuroendocrine Tumors Carcinoma, Small Cell Lung Date: 2016-10-13 Interventions: Drug: PEN-221 Administration of PEN-221 once every three weeks |
Available |
Study Name: An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer Condition: Non-small Cell Lung Cancer Lung Cancer Advanced Malignanci Date: 2016-05-24 Interventions: Drug: Brigatinib Brigatinib will be administered orally to eligible patients with locally advanced or me |
Recruiting |
Study Name: ALTA-1L Study: A Phase 3 Study of Brigatinib Versus Crizotinib in ALK-positive Advanced Non-Small Cell Lung Cancer Patients Condition: Non-small Cell Lung Cancer Lung Cancer Advanced Malignanci Date: 2016-03-30 Interventions: Drug: Brigatinib Brigatinib wi |
Recruiting |
Study Name: A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC Condition: Non-Small Cell Lung Cancer NSCLC Adenocarcinoma Date: 2015-02-12 Interventions: Drug: MM-121 Investigational, |
Recruiting |
Study Name: Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy Condition: Lung Cancer Date: 2015-02-03 Interventions: Radiation: Stereotactic Body Radiotherapy (SABR) SABR once a day for 3-4 days in a row, 50Gy in 4 fracti |
Active, not recruiting |
Study Name: Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Condition: Non-Small Cell Lung Cancer Carcinoma Squamous Cell Carcino Date: 2014-05-28 Interventions: Drug: nab-paclitaxel Other Nam |
Active, not recruiting |
Study Name: A Phase 2, Multicenter, Randomized Study of AP26113 Condition: Non-small Cell Lung Cancer Lung Cancer Advanced Malignanci Date: 2014-03-18 Interventions: Drug: AP26113 90 mg tablet, ta |
Withdrawn |
Study Name: Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer Condition: Carcinoma, Non-Small-Cell-Lung Date: 2012-07-06 Interventions: Drug: Temoporfin A single dose of 0.04 mg per kilogram of body weight of Temoporfin will be administered |
Recruiting |
Study Name: Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix Condition: Cervical Cancer Date: 2012-05-23 Interventions: Behavioral: Questionnaires Completion of online surveys taking approximately 15 - 20 minutes. |